SLBT Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

6.250

Open

4.400

VWAP

5.51

Vol

1.22M

Mkt Cap

3.35B

Low

4.300

Amount

6.71M

EV/EBITDA(TTM)

Total Shares

559.96M

5.04B

EV/OCF(TTM)

P/S(TTM)

SL Science Holding Ltd is a Taiwan-based company mainly engaged in the research and development (R&D) of cell and gene therapies for cancer treatment and regenerative medicine. The Company develops investigational immune cell technologies, including gamma delta (γδ) T cells, Armed-T cells and exosome-based formulations, and operates through its biotechnology and oncology research activities.

Events Timeline

No data

News

2.0

07-03NASDAQ.COM

Biotech Companies See Significant Stock Gains

9.5

06-18Newsfilter

SL Science Reports 2025 Financial Results and Strategic Shift

2.0

06-16Newsfilter

Biotech Companies Achieve Significant Milestones

4.5

06-16NASDAQ.COM

Biotech Stocks Show Significant Pre-Market Activity

4.5

06-16NASDAQ.COM

NASDAQ 100 Pre-Market Update

8.5

06-12Newsfilter

SL Bio Commences Trading on Nasdaq as SLBT

0 Analyst Rating

Wall Street analysts forecast SLBT stock price to rise

0 Buy

0 Hold

0 Sell

Current: 0.000

Low

Averages

High

Current: 0.000

Low

Averages

High

No data

Valuation Metrics

The current forward P/E ratio for SL Science Holding Ltd (SLBT.O) is 0.00, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess SL Science Holding Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

Current PE

0.00

Overvalued PE

Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

Current PS

0.00

Overvalued PS

Undervalued PS

Financials

AI Analysis

Annual

Quarterly

Whales Holding SLBT

Trading Trends

People Also Watch

Frequently Asked Questions

What is SL Science Holding Ltd (SLBT) stock price today?

The current price of SLBT is 5.99 USD — it has increased 34.61

What is SL Science Holding Ltd (SLBT)'s business?

What is the price predicton of SLBT Stock?

Wall Street analysts forecast SLBT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLBT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.